Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts

Journal of the Neurological Sciences

Volumn 151, Issue 1, 1997, Pages 83-87

  Ma, Shuang Yong ^a   Röyttä, Matias ^a   Rinne, Juha O ^a   Collan, Yrjö ^a   Rinne, Urpo K ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Clinical features; Correlation; Disector counts; Parkinson's disease; Substantia nigra

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MORPHOMETRICS; NERVE CELL NECROSIS; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

CASE-CONTROL STUDIES; CELL COUNT; FEMALE; HUMANS; LINEAR MODELS; MALE; NEURONS; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 0342981758     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00100-7     Document Type: Article

References (41)

1. Bernheimer, H., Birkmayer, W., Hornykiewicz, J.K., Seitelberger, F., 1973. Brain dopamine and the syndromes of Parkinson and Huntington. J. Neurol. Sci. 20, 415-455.
2. Bogerts, B., Häntsch, J., Herzer, M., 1983. A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals. Parkinson patients, and schizophrenics. Biol. Psychiat. 18, 951-969.
3. Braendhaard, H., Evans, S.M., Howard, C.V., Gundersen, H.J.G., 1990. The total number of neurons in the human neocortex unbiasedly estimated using optical disectors. J. Microsc. 157,(3) 285-304.
4. Cavalieri, B., 1966. Geometria degli indivisibili. Unione Tipografico-Editrice, Torino.
5. Coggeshall, R.E., 1992. A consideration of neural counting methods. Trends Neurosci. 15, 9-13.
6. Collan, Y., Ma, S.Y., Röyttä, K.T., Rinne, J.O., Rinne, U.K., 1992. Experiences on the use of the disector principle in neuropathology. Acta Stereol. 11, 717-722.
7. Fearnley, J.M., Lees, A.J., 1991. Ageing and Parkinson's disease: Substantia nigra regional selectivity. Brain 114, 2283-2301.
8. German, D.C., Manaye, K., Smith, W.K., Woodward, D.J., Saper, C.B., 1989. Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann. Neurol. 26, 507-514.
9. Gibb, W.R.G., Lees, A.J., 1991. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease. J. Neurol. Neurosurg. Psychiat. 54, 388-396.
10. Goto, S., Hirano, A., Matsumoto, S., 1989. Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration. Ann. Neurol. 26, 766-770.
11. Gundersen, H.J.G., Jensen, E.B., 1987. The efficiency of systematic sampling in stereology and its prediction. J. Microsc. 147, 229-263.
12. Gundersen, H.J.G., Bagger, P., Bendtsen, T.F., Evans, S.M., Korbo, L., Marcussen, N., Møller, A., Nielsen, K., Nyengaard, J.R., Pakkenberg, B., Sørensen, F.B., Vesterby, A., West, M.J., 1988. The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96, 857-881.
13. Hirsch, E., Graybiel, A.M., Agid, Y.A., 1988. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 334, 345-348.
14. Hoehn, M.D., Yahr, M.M., 1967. Parkinsonism: onset, progression and mortality. Neurology 17, 427-442.
15. Hornykiewicz, O., 1966. Metabolism of brain dopamine in human Parkinsonism: Neurochemical and clinical aspects. In: Costa, E. et al. (Eds.), Biochemistry and Pharmacology of the Basal Ganglia. Raven Press, Hewlitt, N.Y., pp. 171-185.
16. Hornykiewicz, O., Kish, S.J., 1986. Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45, 19-34.
17. Janson, A.M., Møller, A., 1993. Chronic nicotine treatment counteracts nigral cell loss induced by partial mesodiencephalic hemitransection: an analysis of the total number and mean volume of neurons and glia in substantia nigra of the male rat. Neuroscience 57,(4) 931-941.
18. Javoy-Agid, F., Ruberg, M., Taquei, H., Bobobza, B., Agid, Y., 1984. Biochemical neuropathology of Parkinson's disease. Adv. Neurol. 40, 189-197.
19. Langston, J.W., 1985. MPTP and Parkinson's disease. Trends Neurosci. 80, 79-83.
20. Lewy, F.H., 1912. Paralysis agitans. I. Pathologische Anatomie. In: Lewandowsky, M. (Ed.), Handbuch der Neurologie. Springer, Berlin.
21. Ma, S.Y., Collan, Y., Röyttä, M., Rinne, J.O., Rinne, U.K., 1995a. Neuronal loss in the substantia nigra: A comparison of single section counts and disector counts in patients with Parkinson's disease. Neuropathol. Appl. Neurobiol. 21, 10-17.
22. Ma, S.Y., Röyttä, M., Rinne, J.O., Collan, Y., Rinne, U.K., 1995b. Single section and disector counts in evaluating neuronal loss from the substantia nigra in patients with Parkinson's disease. Neuropathol. Appl. Neurobiol. 21, 341-343.
23. Ma, S.Y., Rinne, J.O., Collan, Y., Röyttä, M., Rinne, U.K., 1996. A quantitative morphometrical study of the neuron degeneration in the substantia nigra in patients with Parkinson's disease. J. Neurol. Sci. 140, 40-45.
24. Mann, D.M., Yates, P.O., 1982. Pathogenesis of Parkinson's disease. Arch. Neurol. 39,(9) 545-549.
25. Mayhew, T.M., 1992. A review of recent advances in stereology for quantifying neural structure. J. Neurocytol. 21, 313-328.
26. McGeer, P.L., McGeer, E.G., Suzuki, J.S., 1977. Aging and extrapyramidal function. Arch. Neurol. 34, 33-35.
27. Pakkenberg, B., Möller, A., Gundersen, H.J.G., Dam, A.M., Pakkenberg, H., 1991. The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method. J. Neurol. Neurosurg. Psychiat. 54, 30-33.
28. Pakkenberg, H., Brody, H., 1965. The number of nerve cells in the substantia nigra in paralysis agitans. Acta Neuropathol. 5, 320-324.
29. Pakkenberg, B., Gundersen, H.J.G., 1988. Total number of neurons and glial cells in human brain nuclei estimated by the disector and the fractionator. J. Microsc. 150, 1-20.
30. Pakkenberg, B., Gundersen, H.J.G., 1989. New stereological method for obtaining unbiased and efficient estimates of total nerve cell number in human brain areas. APMIS 97, 677-681.
31. Paulus, W., Jellinger, K., 1991. The neuropathological basis of different clinical subgroups of Parkinson's disease. J. Neuropathol. Exp. Neurol. 50,(6) 743-755.
32. Rinne, J.O., Rummukainen, J., Palijärvi, L., Rinne, U.K., 1989. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann. Neurol. 26, 47-50.
33. Rinne, J.O., 1993. Nigral degeneration in Parkinson's disease. Mov Dis 8 Suppl(1), S31-35.
34. Rinne, U.K., Sonninen, V., 1972. Acid monoamine metabolites in the cerebrospinal fluid of patients with Parkinson's disease. Neurology 22, 62-67.
35. Sterio, D.C., 1984. The unbiased estimation of number and sizes of arbitrary particles using the disector. J. Microsc. 134,(2) 127-136.
36. Trétiakoff, C., 1919. Contribution à l'étude de l'anatomie pathologique du locus nigra de Soemmering avec quelques déductions relatives à la pathogénie des troubles de musculaire et de la maladie de Parkinson. Thesis, no 293, Paris.
37. van Domburg, P.H.M.F., 1990. Human brainstem monoaminergic structures in Parkinson's disease and Alzheimer's disease. A neuroanatomical and morphometric analysis. Thesis, University of Nijimegen, pp. 1-190.
38. van Domburg, P.H.M.F., ten Donkelaar, H.J., 1992. The human substantia nigra and ventral tegmental area: A neuroanatomical study with notes on aging and aging disease. Adv. Anat. Embryol. Cell Biol. 121, Springer-Verlag, Berlin, pp. 32-69.
39. West, M.J., 1993a. Regionally specific loss of neurons in the aging human hippocampus. Neurobiol. Aging 14, 287-293.
40. West, M.J., 1993b. New stereological methods for counting neurons. Neurobiol. Aging 4, 275-285.
41. West, M.J., Slomianka, L., Gundersen, H.J., 1993. Unbiased stereological estimation of the total number of neurons in the subdivisions of rat hippocampus using the optical fractionator. Anatomical Records 231, 482-497.